Unknown NA INTERVENTIONAL 2-arm NCT04615858

Genepro Generation 3 Protein Bioavailability Compared to Whey Protein (Gen3)

Genepro Generation 3 Bioavailability Compared to Whey Protein (12g Genepro vs 30g Whey)

Sponsor: Musclegen Research, Inc.

Conditions Absorption; Disorder, Protein Protein Intolerance Protein Malabsorption

Interventions Genepro Generation 3 Protein Whey Protein

Updated 5 times since 2020 Last updated: Nov 9, 2020 Started: Dec 1, 2020 Primary completion: Jan 26, 2021 Completion: Feb 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Absorption; Disorder, Protein and Protein Intolerance, this trial is ongoing. The trial is conducted by Musclegen Research, Inc. and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Musclegen Research, Inc.
WakeMed Bariatric Surgery & Weight Loss Center

Data source: Musclegen Research, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cary, United States
• Raleigh, United States